AIG
RXDX

American International Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

American International Group’s Portfolio RXDX Stock Details RXDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$1.8M Buy
2022
Q4 		$1.81M Buy
2022
Q3 		$858K Buy
2022
Q2 		$387K Sell
2022
Q1 		$562K Sell
2021
Q4 		$630K Buy
2021
Q3 		$147K Sell
2021
Q2 		$156 Buy